The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based studyResearch in context

• Main Authors: Huyen A. Tran (Author), Lucy Deng (Author), Nicholas Wood (Author), Philip Choi (Author), Sally Singleton (Author), Lisa Clarke (Author), Sarah Khanlari (Author), Isis Maitland-Scott (Author), Robert Bird (Author), Scott Brown (Author), Bavahuna Manoharan (Author), Chee Wee Tan (Author), Michael Gold (Author), Pravin Hissaria (Author), Shannon Melody (Author), Sanjeev D. Chunilal S (Author), Jim Buttery (Author), Hazel Clothier (Author), Nigel W. Crawford (Author), Linny Phuong (Author), Dominic Pepperell (Author), Paul Effler (Author), Claire Parker (Author), Nicola Carter (Author), Kristine Macartney (Author), Megan McStea (Author), Todd Miller (Author), Michael Nissen (Author), Claire Larter (Author), Elspeth Kay (Author), Vivien M. Chen (Author)
• Format: Book
• Published: Elsevier, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Thrombosis with thrombocytopenia syndrome (TTS) associated with viral vector COVID-19 vaccines, including ChAdOx1-S (AstraZeneca AZD1222) vaccine, can result in significant morbidity and mortality. We report the clinicopathological features of TTS following ChAdOx1-S vaccination...